Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[RNA interference for mammalian cells].

Hiroyuki Oshiumi1, Nasim A Begum, Misako Matsumoto

  • 1Osaka Medical Center for Cancer, CREST JST, Higashinari-ku, Osaka 537-8511, Japan. osiumi-hi@mc.pref.osaka.jp

Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|August 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The nucleolar protein NOP16 suppresses TGF-β-regulated IgA class switch recombination in B cells by regulating AID induction.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Position-5-driven reorientation of an immunodominant HLA-A*24:02 SARS-CoV-2 epitope drives universal T cell escape.

JCI insight·2026
Same author

Therapeutic Efficacy of the Supersulfide Donor NAC-S2 in Influenza Virus Pneumonia via Suppression of Excessive Inflammatory Responses.

Microbiology and immunology·2026
Same author

Molecular mechanism of MDA5 nucleation and filament formation by LGP2.

Molecular cell·2026
Same author

Lipid nanoparticle-encapsulated microRNA-192: An anti-inflammatory adjuvant that enhances vaccine efficacy in aged mice.

Molecular therapy. Nucleic acids·2025
Same author

hnRNPL-CstF64 complex: coordinating CSR and LSR in IgH locus recombination dynamics through eRNA and NHEJ regulation.

Nucleic acids research·2025
Same journal

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Prediction of severe oral mucositis in cancer treatment: the role of the oral-gut axis in precision supportive care].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Iron dysregulation and ferroptosis in heart failure: the dual faces of deficiency and overload].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Pharmacological characteristics and clinical outcomes of Rimegepant (Nurtec<sup>®</sup> ODT), an oral CGRP receptor antagonist for the acute treatment and prevention of migraine].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Pharmacological properties and clinical trial results of datopotamab deruxtecan (Dato-DXd, Datroway<sup>®</sup>)].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Oxytocin regulates social familiarity-dependent mate choice in medaka].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
See all related articles

RNA interference (RNAi) offers a faster method for gene silencing in mammalian cells. Short interfering RNA (siRNA) effectively suppresses target gene translation without activating PKR, overcoming previous limitations.

Area of Science:

  • Molecular Biology
  • Genetics

Context:

  • Mammalian gene knock-out is challenging and time-consuming.
  • RNA interference (RNAi) is effective in lower organisms but was previously difficult in mammalian cells due to PKR activation.
  • Recent advancements have enabled RNAi in mammalian systems.

Purpose:

  • To describe the development and application of RNA interference (RNAi) for gene silencing in mammalian cells.
  • To introduce small interfering RNA (siRNA) as a method to overcome PKR activation and achieve specific gene silencing.
  • To highlight the efficiency and potential of RNAi for mammalian gene knockdown.

Summary:

  • Gene silencing in mammalian cells was previously difficult due to bystander activation of protein kinase (PKR) by long double-stranded RNA (dsRNA).
  • A breakthrough utilized 20- or 21-nucleotide small interfering RNAs (siRNAs), processed by DICER, which mediate RNAi with minimal PKR activation.

Related Experiment Videos

  • Synthesized siRNAs and vector-based expression systems now allow for specific, efficient gene silencing in cultured mammalian cells, overcoming previous limitations.

    • Impact:

    • RNA interference (RNAi) provides a rapid and labor-efficient method for targeting gene expression in mammalian systems.
    • This technique facilitates functional genomics and potential therapeutic applications by enabling precise gene knockdown.
    • Mammalian gene knockdown via RNAi is expected to become a widely adopted research tool due to its simplicity and effectiveness.